These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 769114)

  • 21. Effect of clozapine on the turnover of dopamine in the corpus striatum and in the limbic system.
    Andén NE; Stock G
    J Pharm Pharmacol; 1973 Apr; 25(4):346-8. PubMed ID: 4146695
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of dimethoxy dichloro vinyl phosphate and fluorostigmine on the cyclic nucleotide content and dopamine level in the brain nigrostriatal system].
    Golovko AI; Korovkin BF; Kutsenko SA; Savateev NV
    Farmakol Toksikol; 1985; 48(2):46-8. PubMed ID: 3996569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopaminergic infllence in the basal ganglia: evidence for striatonigral feedback regulation.
    Bunney BS; Aghajanian GK
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():249-67. PubMed ID: 826996
    [No Abstract]   [Full Text] [Related]  

  • 24. [Tremor and motility following oxotremorine and harmine in rats with lesions of the nigro-striatal system].
    Westermann KH; Oelszner W; Staib AH; Funk K
    Acta Biol Med Ger; 1974; 33(1):67-76. PubMed ID: 4153886
    [No Abstract]   [Full Text] [Related]  

  • 25. Dopaminergic regulation of cholinergic neurons in the striatum: relation to Parkinsonism.
    Bartholini G; Lloyd KG; Stadler H
    Adv Neurol; 1974; 5():11-4. PubMed ID: 4440567
    [No Abstract]   [Full Text] [Related]  

  • 26. Regional and ultrastructural localization of tyrosine hydroxylass by immunocytochemistry in dopaminergic neurons of the mesolimbic and nigroneostriatal systems.
    Pickel VM; Joh TH; Reis DJ
    Adv Biochem Psychopharmacol; 1977; 16():321-9. PubMed ID: 18885
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of the effects of (-)deprenyl, 1-phenyl-2-propyl-aminopentane (MK-306) and amphetamine on the striatal and limbic dopaminergic system.
    Timár J; Yasar S; Knoll B; Knoll J
    Acta Physiol Hung; 1990; 75 Suppl():279-80. PubMed ID: 2115233
    [No Abstract]   [Full Text] [Related]  

  • 28. [The role of dopamine in the physiology and pathology of the basal ganglia].
    Arushanian EB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(4):595-603. PubMed ID: 4341763
    [No Abstract]   [Full Text] [Related]  

  • 29. A dopaminergic-cholinergic mechanism in production of psychotic symptoms.
    Friedhoff AJ; Alpert M
    Biol Psychiatry; 1973 Apr; 6(2):165-9. PubMed ID: 4709131
    [No Abstract]   [Full Text] [Related]  

  • 30. Differential effect of acute and chronic ethanol on dopamine metabolism in frontal cortex, caudate nucleus and substantia nigra.
    Fadda F; Argiolas A; Melis MR; Serra G; Gessa GL
    Life Sci; 1980 Sep; 27(11):979-86. PubMed ID: 7432099
    [No Abstract]   [Full Text] [Related]  

  • 31. Self-injurious behavior and dopaminergic neuron system in neonatal 6-hydroxydopamine-lesioned rat: 1. Dopaminergic neurons and receptors.
    Yokoyama C; Okamura H
    J Pharmacol Exp Ther; 1997 Feb; 280(2):1016-30. PubMed ID: 9023319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disruption of EphA/ephrin-a signaling in the nigrostriatal system reduces dopaminergic innervation and dissociates behavioral responses to amphetamine and cocaine.
    Sieber BA; Kuzmin A; Canals JM; Danielsson A; Paratcha G; Arenas E; Alberch J; Ogren SO; Ibáñez CF
    Mol Cell Neurosci; 2004 Jul; 26(3):418-28. PubMed ID: 15234346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between asymmetries in striatal dopamine release and the direction of amphetamine-induced rotation during the first week following a unilateral 6-OHDA lesion of the substantia nigra.
    Robinson TE; Noordhoorn M; Chan EM; Mocsary Z; Camp DM; Whishaw IQ
    Synapse; 1994 May; 17(1):16-25. PubMed ID: 8042143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of the push-pull cannula to estimate the dynamics of acetylcholine and catecholamines within various brain areas.
    Bartholini G; Stadler H; Ciria MG; Lloyd KG
    Neuropharmacology; 1976 Sep; 15(9):515-9. PubMed ID: 980227
    [No Abstract]   [Full Text] [Related]  

  • 35. Behavioral effects of direct- and indirect-acting dopaminergic agonists.
    Moore KE
    Adv Biochem Psychopharmacol; 1974; 12(0):403-14. PubMed ID: 4371765
    [No Abstract]   [Full Text] [Related]  

  • 36. Neuropeptides in the basal ganglia.
    Graybiel AM
    Res Publ Assoc Res Nerv Ment Dis; 1986; 64():135-61. PubMed ID: 2425403
    [No Abstract]   [Full Text] [Related]  

  • 37. Dopamine in substantia nigra and cortex after gamma-butyrolactone treatment.
    Pericić D; Walters JR
    J Pharm Pharmacol; 1976 Jun; 28(6):527-30. PubMed ID: 7658
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of chronically administered L-dopa in normal and lesioned cats.
    Langelier P; Roberge AG; Boucher R; Poirier LJ
    J Pharmacol Exp Ther; 1973 Oct; 187(1):15-26. PubMed ID: 4746324
    [No Abstract]   [Full Text] [Related]  

  • 39. Antagonism by neuroleptics of abnormal behavior induced by activation of brain dopamine receptors.
    Van Rossum JM
    Mod Probl Pharmacopsychiatry; 1970; 5():65-7. PubMed ID: 5527171
    [No Abstract]   [Full Text] [Related]  

  • 40. Barbiturates and meprobamate: decreases in cathecholamine turnover of central dopamine and noradrenaline neuronal systems and the influence of immobilization stress.
    Lidbrink P; Corrodi H; Fuxe K; Olson L
    Brain Res; 1972 Oct; 45(2):507-24. PubMed ID: 4404488
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.